4.6 Review

Extracellular matrix-based cancer targeting

期刊

TRENDS IN MOLECULAR MEDICINE
卷 27, 期 10, 页码 1000-1013

出版社

CELL PRESS
DOI: 10.1016/j.molmed.2021.07.009

关键词

-

资金

  1. Action for the Strategic Development on the Research and Technological Sector - Operational Programme Competitiveness, Entrepreneurship and Innovation (NSRF 2014-2020) [MIS5045810]
  2. European Union (European Regional Development Fund)
  3. Israel Science Foundation (ISF) [1021/19]
  4. Israel Cancer Research Fund (ICRF)
  5. Deutsche Forschungsgemeinschaft [DFG GO1392/8-1]
  6. Regione Lombardia [1736987 -CUPE37B200001200 07]
  7. NSRF 2014-2020 [MIS5033644]
  8. French Agence Nationale de la Recherche [ANR-18-CE92-0035-01]
  9. Rhone-Auvergne Pack Ambition Recherche 2020

向作者/读者索取更多资源

Tumor extracellular matrix collaborates with cancer and stroma cells to facilitate the multistep process of metastasis, highlighting the importance of ECM networks in cancer therapeutics and diagnostics.
Tumor extracellular matrix (ECM) operates in a coordinated mode with cancer and stroma cells to evoke the multistep process of metastatic potential. The remodeled tumor-associated matrix provides a point for direct or complemen-tary therapeutic targeting. Here, we cover and critically address the importance of ECM networks and their macromolecules in cancer. We focus on the roles of key structural and functional ECM components, and their degradation enzymes and extracellular vesicles, aiming at improving our understanding of the mecha-nisms contributing to tumor initiation, growth, and dissemination, and discuss potential new approaches for ECM-based therapeutic targeting and diagnosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据